Global analysis of differentially expressed genes in androgen-independent prostate cancer

Progression to androgen independent (AI) is the main cause of death in prostate cancer, and the mechanism is still unclear. By reviewing the expression profiles of 26 prostate cancer samples in a holistic view, we found a group of genes differentially expressed in AI compared with androgen-dependent groups (P-value<0.01, t-test). Focusing on apoptosis, proliferation, hormone and angiogenesis, we found a group of genes such as thioredoxin domain containing 5 , tumor necrosis factor receptor superfamily, member 10a , ribosomal protein S19 and Janus kinase 2 upregulated in AI prostate cancer, could play important roles in the transition from AD to AI and could be biomarkers of prognosis.

[1]  Y. Nakamura,et al.  [Colorectal cancers]. , 1997, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.

[2]  K. Sjögren,et al.  Estrogen inhibits GH signaling by suppressing GH-induced JAK2 phosphorylation, an effect mediated by SOCS-2 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[3]  J. Takita,et al.  An immunohistochemical study of TIMP-3 expression in oesophageal squamous cell carcinoma , 2004, British Journal of Cancer.

[4]  C. Wild,et al.  Tissue inhibitor of metalloproteinase‐3 (TIMP‐3) gene is methylated in the development of esophageal adenocarcinoma: Loss of expression correlates with poor prognosis , 2005, International journal of cancer.

[5]  Y. Kudo,et al.  Small interfering RNA targeting of S phase kinase – interacting protein 2 inhibits cell growth of oral cancer cells by inhibiting p 27 degradation , 2005 .

[6]  Takao Takahashi,et al.  Polo‐like kinase 1 (PLK1) is overexpressed in primary colorectal cancers , 2003, Cancer science.

[7]  M. Sitrin,et al.  Regulation of calbindin-D9k expression by 1,25-dihydroxyvitamin D(3) and parathyroid hormone in mouse primary renal tubular cells. , 2002, Archives of biochemistry and biophysics.

[8]  J. Baselga,et al.  TACE is required for the activation of the EGFR by TGF-alpha in tumors. , 2003, The EMBO journal.

[9]  E. Rosen,et al.  Constitutive activation of JAK–STAT3 signaling by BRCA1 in human prostate cancer cells , 2001, FEBS letters.

[10]  Kang Ying,et al.  Discovery and analysis of hepatocellular carcinoma genes using cDNA microarrays , 2002, Journal of Cancer Research and Clinical Oncology.

[11]  S. Koyama,et al.  Expression of TNF-related apoptosis-inducing ligand (TRAIL) and its receptors in gastric carcinoma and tumor-infiltrating lymphocytes: a possible mechanism of immune evasion of the tumor , 2002, Journal of Cancer Research and Clinical Oncology.

[12]  C. Bellido,et al.  Differences in Prepuberal Neonatally Estrogenized or Androgenized Male Rats , 2009, Andrologia.

[13]  D. Macneil,et al.  Short segment of human melanin-concentrating hormone that is sufficient for full activation of human melanin-concentrating hormone receptors 1 and 2. , 2001, Biochemistry.

[14]  G. Camussi,et al.  CD40-dependent Activation of Phosphatidylinositol 3-Kinase/Akt Pathway Mediates Endothelial Cell Survival and in Vitro Angiogenesis* , 2003, The Journal of Biological Chemistry.

[15]  A. Poustka,et al.  Deleted in Malignant Brain Tumors 1 is a versatile mucin-like molecule likely to play a differential role in digestive tract cancer. , 2001, Cancer research.

[16]  S. Batra,et al.  Expression of ADAMs (a disintegrin and metalloproteases) and TIMP-3 (tissue inhibitor of metalloproteinase-3) in human prostatic adenocarcinomas. , 2003, International journal of oncology.

[17]  R. Poulsom,et al.  EndoPDI, a Novel Protein-disulfide Isomerase-like Protein That Is Preferentially Expressed in Endothelial Cells Acts as a Stress Survival Factor* , 2003, Journal of Biological Chemistry.

[18]  Maria D Person,et al.  Annexin II expression is reduced or lost in prostate cancer cells and its re-expression inhibits prostate cancer cell migration , 2003, Oncogene.

[19]  B. He,et al.  Identification of differentially expressed genes in human uterine leiomyomas using differential display , 2002, Cell Research.

[20]  F. Hamdy,et al.  The expression and regulation of ADAMTS‐1, ‐4, ‐5, ‐9, and ‐15, and TIMP‐3 by TGFβ1 in prostate cells: relevance to the accumulation of versican , 2005, The Prostate.

[21]  Janghoo Lim,et al.  Novel Transcription Coactivator Complex Containing Activating Signal Cointegrator 1 , 2002, Molecular and Cellular Biology.

[22]  Andrew J. Holloway,et al.  Options available—from start to finish—for obtaining data from DNA microarrays II , 2002, Nature Genetics.

[23]  Mamoru Fukuda,et al.  Down-regulation of BRCA1-BARD1 ubiquitin ligase by CDK2. , 2005, Cancer research.

[24]  T. H. van der Kwast,et al.  Androgen Pathway Dysregulation in BRCA1-Mutated Breast Tumors , 2003, Breast Cancer Research and Treatment.

[25]  A. Poustka,et al.  DMBT1 expression is down-regulated in breast cancer , 2004, BMC Cancer.

[26]  C. Olsson,et al.  Prostatic expression of hensin, a protein implicated in epithelial terminal differentiation , 2001, The Prostate.

[27]  K. Shigemasa,et al.  Skp 2 Overexpression Is a Prognostic Factor in Patients with Ovarian Adenocarcinoma 1 , 2003 .

[28]  R. D'Amato,et al.  Angiogenic potential of prostate carcinoma cells overexpressing bcl-2. , 2001, Journal of the National Cancer Institute.

[29]  D. Hougaard,et al.  Carboxypeptidase E in rat antropyloric mucosa: distribution in progenitor and mature endocrine cell types , 2003, Histochemistry and Cell Biology.

[30]  W. Tilley,et al.  Vascular endothelial growth factor (VEGF) expression in prostate cancer and benign prostatic hyperplasia. , 1997, The Journal of urology.

[31]  C. Logothetis,et al.  The clinical and biological study of androgen independent prostate cancer (AI PCa). , 1994, Seminars in oncology.

[32]  S. Loening,et al.  Polo‐like kinase 1 is overexpressed in prostate cancer and linked to higher tumor grades , 2004, The Prostate.

[33]  Sanjit K. Mitra,et al.  Optimized LOWESS normalization parameter selection for DNA microarray data , 2004, BMC Bioinformatics.

[34]  Jianghong Li,et al.  Janus Kinase 2 Signaling in the Angiotensin II‐Dependent Activation of StAR Expression , 2004, Endocrine research.

[35]  J. Gillette,et al.  Annexin 2 expression is reduced in human osteosarcoma metastases , 2004, Journal of cellular biochemistry.

[36]  R. Rodriguiz,et al.  Deficits in reproduction and pro-gonadotropin-releasing hormone processing in male Cpefat mice. , 2004, Endocrinology.

[37]  Holger Schulz,et al.  The F-box protein SKP2 mediates androgen control of p27 stability in LNCaP human prostate cancer cells , 2002, BMC Cell Biology.

[38]  F. Jiang,et al.  RNA silencing of S-phase kinase-interacting protein 2 inhibits proliferation and centrosome amplification in lung cancer cells , 2005, Oncogene.

[39]  T. Buchler,et al.  Chemotherapy for hormone-resistant prostate cancer: Where are we today? , 2007, Indian journal of urology : IJU : journal of the Urological Society of India.

[40]  I. Leav,et al.  Androgen‐supported estrogen‐enhanced epithelial proliferation in the prostates of intact noble rats , 1989, The Prostate.

[41]  T. Stokke,et al.  Repression of mRNA for the PLK cell cycle gene after DNA damage requires BRCA1 , 2003, Oncogene.

[42]  G. Bubley,et al.  Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. , 1995, The New England journal of medicine.

[43]  J. Franklyn,et al.  Transcriptional regulation of the human glycoprotein hormone common alpha subunit gene by cAMP-response-element-binding protein (CREB)-binding protein (CBP)/p300 and p53. , 2002, The Biochemical journal.

[44]  Xiaoqi Liu,et al.  Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[45]  M. Slongo,et al.  Expression of Matrix Metalloproteases (MMP-2, MT1-MMP) and Their Tissue Inhibitor (TIMP-2) by Rat Sertoli Cells in Culture: Implications for Spermatogenesis , 2002, Biological chemistry.

[46]  A. Ullrich,et al.  Distinct ADAM Metalloproteinases Regulate G Protein-coupled Receptor-induced Cell Proliferation and Survival* , 2004, Journal of Biological Chemistry.

[47]  P. Cooke,et al.  CD40 expression in prostate cancer: a potential diagnostic and therapeutic molecule. , 2004, Oncology reports.

[48]  J. Overgaard,et al.  Association between immunohistochemical expression of vascular endothelial growth factor (VEGF), VEGF-expressing neuroendocrine-differentiated tumor cells, and outcome in prostate cancer patients subjected to watchful waiting. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[49]  H. Klocker,et al.  Identification of genes involved in estrogenic action in the human prostate using microarray analysis. , 2004, Genomics.

[50]  Jia-qing Li,et al.  Correlation of Skp2 with carcinogenesis, invasion, metastasis, and prognosis in colorectal tumors. , 2004, International journal of oncology.

[51]  J. Baselga,et al.  TACE is required for the activation of the EGFR by TGF‐α in tumors , 2003 .

[52]  J. Viikari,et al.  C3, hormone-sensitive lipase, and peroxisome proliferator-activated receptor gamma expression in adipose tissue of familial combined hyperlipidemia patients. , 2002, Metabolism: clinical and experimental.

[53]  M. D'Andrea,et al.  The putative tumor suppressor deleted in malignant brain tumors 1 is an estrogen-regulated gene in rodent and primate endometrial epithelium. , 2005, Endocrinology.

[54]  N. Weidner,et al.  Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[55]  Y. Kudo,et al.  Small interfering RNA targeting of S phase kinase–interacting protein 2 inhibits cell growth of oral cancer cells by inhibiting p27 degradation , 2005, Molecular Cancer Therapeutics.

[56]  Yi Sun,et al.  Autocrine Human Growth Hormone Inhibits Placental Transforming Growth Factor-β Gene Transcription to Prevent Apoptosis and Allow Cell Cycle Progression of Human Mammary Carcinoma Cells* , 2002, The Journal of Biological Chemistry.

[57]  Xiang Ding,et al.  ADAM17 mRNA expression and pathological features of hepatocellular carcinoma. , 2004, World journal of gastroenterology.

[58]  M. Tatsuta,et al.  Expression of S100A6 and S100A4 in Matched Samples of Human Colorectal Mucosa, Primary Colorectal Adenocarcinomas and Liver Metastases , 2002, Oncology.

[59]  Ming-Rong Wang,et al.  Analysis of gene expression profile induced by EMP-1 in esophageal cancer cells using cDNA Microarray. , 2003, World journal of gastroenterology.

[60]  D. S. Coffey,et al.  The differential effects of neonatal androgen, estrogen and progesterone on adult rat prostate growth. , 1986, The Journal of urology.

[61]  L. Claesson‐Welsh,et al.  A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2 , 2003, Nature Medicine.

[62]  Steven P. Angus,et al.  Hierarchical Requirement of SWI/SNF in Retinoblastoma Tumor Suppressor-mediated Repression of Plk1* , 2004, Journal of Biological Chemistry.